Status:
RECRUITING
Coronary Bifurcations With Ischaemia and Flow Assessment
Lead Sponsor:
University of East Anglia
Collaborating Sponsors:
Norfolk and Norwich University Hospitals NHS Foundation Trust
Conditions:
Coronary Bifurcation Lesions
Eligibility:
All Genders
18+ years
Brief Summary
The coronary arteries are blood vessels that provide oxygen rich blood to the muscle of the heart. If these vessels become narrowed or blocked, this can lead to chest pain (called angina) or heart att...
Eligibility Criteria
Inclusion
- Age 18 or over
- Any bifurcation lesion amenable to a provisional main vessel treatment strategy
- A main vessel diameter of 2.5mm or more and side branch diameter of \>2mm
- Any patient with stable angina, silent ischaemia, unstable angina or NSTEMI
- Able to give informed consent
Exclusion
- Cardiogenic shock
- LVEF \<30%
- STEMI (as unable to give informed consent)
- eGFR \<30
- Severe asthma contraindicating use of adenosine
- High degree AV block on 12 lead ECG precluding the use of adenosine
- Pregnancy
- Inability to consent
- Left main stem coronary bifurcation lesions
Key Trial Info
Start Date :
October 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06971718
Start Date
October 10 2023
End Date
June 1 2026
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwich Medical School, University of East Anglia
Norwich, Norfolk, United Kingdom, NR47TJ